HHS plans to shutter or downsize several health agencies, including at CDC
The Department of Health and Human Services said Thursday it plans to cut 10,000 full-time jobs across several agencies, as part of a broader effort by the Trump administration to restructure many parts of the federal government.
The cuts, part of the White House's 'reduction in force' plan, were expected to effectively shutter or downsize multiple departments at the Centers for Disease Control and Prevention and other health agencies, potentially jeopardizing public health efforts.
HHS oversees 13 agencies, including the CDC, the Food and Drug Administration and the National Institutes of Health.
HHS said Thursday that 28 divisions in the health department contain 'redundant units,' and the restructuring plan will consolidate them into 15 divisions.
Among the divisions being eliminated or reduced at the CDC, HHS said, are those focused on global health, domestic HIV prevention and prevention from injury, such as gun violence.
The administration also made cuts to divisions at other agencies tasked with responding to approving new drugs, providing health insurance and responding to infectious disease outbreaks.
The cuts were separate from earlier attempts by government officials to fire thousands of probationary employees at the CDC and other federal agencies. Two federal judges have since ordered the temporary reinstatement of many of those affected workers.
Federal health officials had previously said they planned to shift responsibilities from some eliminated departments to other parts of HHS.
For example, the Trump administration was considering a plan to move the responsibilities of CDC's Division on HIV Prevention over to the Health Resources and Services Administration, which does its own HIV work under The Ryan White HIV/AIDS program.
However, HRSA is primarily focused on the treatment of HIV rather than preventing it, leaving some HIV advocates concerned it could drive back progress on prevention.
It was unclear Thursday whether that was still the administration's plan. A spokesperson for HHS did not immediately respond to a request for additional comment.
Much of the responsibility for the newly downsized agencies at the CDC will likely be left to Susan Monarez, Trump's pick to lead the agency and its current acting director.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
2 hours ago
- Daily Mail
Major HIV breakthrough forces hidden fragments of the virus to emerge so it can be cleared from the body
Experts could have found a way to be one step closer to curing HIV for good. Researchers in Australia has developed a new treatment that forces hidden fragments of the virus - normally concealed within human cells - to emerge and expose themselves to the immune system. The breakthrough could enable the body, aided by antiviral drugs, to detect and destroy any lingering viral reservoirs. HIV has remained incurable because the virus can integrate itself into a cell's DNA, laying dormant and undetectable to both medication and immune defenses. Scientists said they've created a nanoparticle capable of delivering genetic instructions to infected cells, prompting them to produce a signal that reveals the virus's presence. Dr Paula Cevaal of the Doherty Institute and co-author of the study told The Guardian that the feat was 'previously thought impossible'. Cevaal said: 'In the field of biomedicine, many things eventually don't make it into the clinic, that is the unfortunate truth; I don't want to paint a prettier picture than what is the reality. 'But in terms of specifically the field of HIV cure, we have never seen anything close to as good as what we are seeing, in terms of how well we are able to reveal this virus. 'So, from that point of view, we're very hopeful that we are also able to see this type of response in an animal, and that we could eventually do this in humans.' The discovery was first revealed in the journal Nature Communications, where researchers said they were initially so astonished that they had to rerun the tests. Further research would be needed to determine whether revealing the virus would be enough to trigger an immune response, with tests only being carried out in the lab. It could still take years before clinical trials for the drug began, when it would have to go through rigorous testing before reaching consumers. However, the advance represents another step forward for the 1.2 million Americans currently living with an HIV infection - for which they took drugs daily. An estimated 31,800 people were believed to be infected every year, although that's a 12 per cent decline on five years ago. Globally, nearly 40 million people have the virus. The new nanoparticle's based on mRNA technology, the same as was used in covid vaccines made by Pfizer and other vaccine manufacturers. In their paper, the scientists revealed that they could deliver mRNA instructions to cells using the nanoparticle. The mRNA then instruct cells to generate substances that reveal the presence of HIV, but only if the virus was present. The study done in the laboratory was carried out in cells donated by HIV patients.
Scotsman
2 hours ago
- Scotsman
warning signs of Victorian era STI
There is concern after the latest data showed cases of syphilis had continued to rise 🏥 Sign up to our daily newsletter – Regular news stories and round-ups from around Scotland direct to your inbox Sign up Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... The UK Health and Security Agency (UKHSA) has published its latest data on sexually transmitted infections (STI). Concerningly cases of syphilis, an STI most commonly associated with the Victorian era have continued to rise. If left untreated, syphilis can cause serious and potentially life-threatening complications. Cases of a Victorian era sexually transmitted infection (STI), are continuing to increase, latest data from the UKHSA has shown. Syphilis, is an STI that was once believed to be a thing of the past, however, cases are 'concerningly' on the rise in 2024, compared to 2023. Advertisement Hide Ad Advertisement Hide Ad Overall, there was a 2% rise (9,535) in diagnoses of early-stage syphilis in 2024 compared to 2023 (9,375), whilst 'concerningly', figures rose to 5% for late-stage syphilis, increasing from 12,456 in 2023 to 13,030 in 2024. If left untreated, syphilis can cause serious, irreversible and potentially life-threatening problems with your brain, heart, or nerves. Dr Hamish Mohammed, Consultant Epidemiologist at UKHSA, said: 'Levels of STIs in this country remain a big threat to sexual wellbeing. These infections can have a major impact on your health and that of any sexual partners, particularly if they are antibiotic resistant. 'If you've had condomless sex with new or casual partners, either in the UK or overseas, get tested for STIs and HIV at least yearly, even if you don't have symptoms. Regular testing protects both you and those you're having sex with.' Advertisement Hide Ad Advertisement Hide Ad New data from the UK Health Security Agency (UKHSA) shows that syphilis cases have continued to rise. |What is syphilis? Syphilis is a sexually transmitted infection (STI), that is passed on through unprotected sexual contact. Most commonly associated with the Victorian era, it is still prevalent, with cases 'concerningly', continue to rise in the UK. What are the symptoms of syphilis? Symptoms of syphilis can take up to three weeks to appear after being infected. They can be mild and come and go, but the infection will remain and you will be able to pass it on. This is why if you suspect you have syphilis or have symptoms it's important to get tested. The NHS explain symptoms of syphilis include: small sores (ulcers) on your penis, vagina, or around your bottom (anus) sores in other areas, including in your mouth or on your lips, hands or bottom white or grey warty growths most commonly on your penis, vagina or around your anus a rash on the palms of your hands and soles of your feet that can sometimes spread all over your body white patches in your mouth flu-like symptoms, such as a high temperature, headaches and tiredness swollen glands patchy hair loss on the head, beard and eyebrows Who is at risk of syphilis? You are at risk of syphilis if you have unprotected sexual contact (vaginal, anal or oral), with someone who is infected with syphilis. Advertisement Hide Ad Advertisement Hide Ad The STI can also be passed onto unborn babies or can spread through injecting drugs with a needle that has been used by someone who is infected, in very rare cases it can also be passed on through blood or organ transplants, although in the UK all blood and organ donations are checked for syphilis. How is syphilis treated? Syphilis is treated with antibiotics, it's important not to engage in sexual contact until you have completed your treatment and had a test that has confirmed you are over the infection. If you have a partner, do not have sexual contact until they have also been treated and a test has confirmed they no longer have syphilis. If left untreated, syphilis can cause serious, irreversible and potentially life-threatening problems with your brain, heart, or nerves. This is why it's so important to seek treatment as soon as you suspect you have been exposed or have symptoms.
Reuters
7 hours ago
- Reuters
Contraceptives for poorest countries stuck in warehouses after US aid cuts
LONDON, June 5 (Reuters) - Contraceptives that could help prevent millions of unwanted pregnancies in some of the world's poorest countries are stuck in warehouses because of U.S. aid cuts and could be destroyed, two aid industry sources and one former government official said. The stock, held in Belgium and Dubai, includes condoms, contraceptive implants, pills and intrauterine devices, together worth around $11 million, the sources told Reuters. It has been stalled since the Trump administration started cutting foreign aid as part of its 'America First' policy in February, as the U.S. government no longer wants to donate the contraceptives or pay the costs for delivery, they said. The U.S. Agency for International Development (USAID) has instead asked the contractor managing its health supply chain, Chemonics, to try to sell it, two of the sources said. An internal USAID memo, sent in April, said a quantity of contraceptives was being kept in warehouses and they should be "immediately transferred to another entity to prevent waste or additional costs". A senior U.S. State Department official told Reuters no decision had been made about the future of the contraceptives. They did not respond to questions about the reasons why the contraceptives were in storage or the impact of the U.S. aid cuts and delays. A spokesperson for Chemonics said they were unable to comment on USAID's plans, but added that the company is working with clients to deliver life-saving aid globally and would continue to support the U.S. government's global health supply chain priorities. The stock represents just under 20% of the supply of contraceptives bought annually by the U.S. for donation overseas, a former USAID official told Reuters. Selling or donating the contraceptives has been challenging, according to the former USAID official, although talks are ongoing. Another option on the table is destroying it, at a cost of several hundred thousand dollars. As time goes on, shelf-lives will also become an issue, one of the sources said. The sources told Reuters that one of the key delays is a lack of response from the U.S. government about what should be done with the stock. It had been destined largely for vulnerable women in sub-Saharan Africa, including young girls who face higher health risks from early pregnancy as well as those fleeing conflict or who otherwise could not afford or access the contraceptives, the sources added. The condoms also help stop the spread of HIV, the former USAID official said. "We cannot dwell on an issue for too long; when urgency and clarity don't align, we have to move on," said Karen Hong, chief of UNFPA's supply chain. She said the agency is now working on Plan B to help fill critical supply gaps.
